|
ASIPP is proud to announce that Mayor Rudolph "Rudy" Giuliani will be addressing the attendees of the 2017 ASIPP Annual Meeting to be held April 20- 22, 2017 in Las Vegas. Mayor Giuliani will be one of our keynote speakers on Saturday, August 22, 2017 at Caesar's Palace in Vegas.
You are not going to want to miss this year's meeting!
Mayor Giuliani joins our prestigious panel of guest speakers lined up for this year's meeting including: Including
- Chairman Greg Walden, Chairman of House Energy and Commerce Committee
- Congressman Ed Whitfield, Long-time friend of ASIPP and recently retired Congressman for Kentucky
Other speakers are:
- Abraham Verghese, MD, MACP - Keynote Speaker Stanford University School of Medicine, Stanford, CA (http://abrahamverghese.com/) Abraham Verghese is a physician-author, Professor for the Theory and Practice of Medicine at Stanford University Medical School and Senior Associate Chair of the Department of Internal Medicine.
- Robert Wachter, MD University of California San Francisco School of Medicine, San Francisco, CA https://www.bigspeak.com/speakers/robert-wachter Dr. Robert Wachter is Professor and Associate Chair of the Department of Medicine at the University of California, San Francisco. He was named one of the 50 most influential physicians in the U.S. for each of the past 7 years.
- Robert Laszewski President, Health Policy and Strategy Associates, LLC www.healthpol.com/ Robert Laszewski is a frequent speaker at ASIPP events. He is the president of Health Policy and Strategy Associates, Inc. (HPSA), a policy and marketplace consulting firm dealing with health policy and market change.
- Richard North, MD President, the Neuromodulation Foundation, Inc. Dr. Richard North has directed the Neurosurgery Spine Service for 16 years at the Johns Hopkins University School of Medicine. He has received The American Academy of Pain Medicine's Founder's Award, and the North American Neuromodulation Society's Lifetime Achievement Award in the field of implanted electrical stimulation devices.
- Philippe Hernigou, MD - Keynote Speaker Chief of Surgery & Professor of Hospital Henri Mondor, University, Paris. Dr. Hernigou served as a Member of the Board of Scientific Advisors of Stemedica Cell Technologies, Inc. He has used autologous bone marrow concentrate (BMC) to treat orthopedic pathologies since 1990.
- Peter Staats, MD, Immediate Past President, ASIPP
- Tim Coan, Chief Executive Officer, ALN Medical Management
- Devi E. Nampiaparampil, MD, Assistant Professor, Anesthesiology and Rehabilitation, NYU
- Laxmaiah Manchikanti, Chairman of the Board and CEO, ASIPP
|
|
|
SUBMIT YOUR ABSTRACT TODAY!
- Selected manuscripts will be presented in electronic poster presentation.
- 25 will be published in Pain Physician.
- Top 10 will be selected for abstract presentation at meeting.
- Top 3 will receive cash prizes.
Proposals will be accepted until February 28, 2017
|
|
|
ASIPP Releases Opioid Guidelines for Responsible, Safe, Effective, and Approach to Prescribing Opioids for Chronic Non-cancer Pain
|
The American Society of Interventional Pain Physicians (ASIPP) is releasing revised recommendations that are responsible, safe, effective, and provide a balanced approach to prescribing opioids for chronic non-cancer pain in order to curtail opioid abuse and at the same time maintain access to the medically needed use of prescription pain medications.
These guidelines are featured in a special issue of Pain Physician journal set to be released on March 1, 2017. (Available online today at www.painphysicianjournal.com)
The guidelines recommend that opioids be prescribed only after extensive assessment with proper monitoring in only patients with persistent pain in minimally effective doses. This is the latest update since 2013 and includes some of the recommendations from the recently released CDC guidelines.
These guidelines come at a time that we are experiencing an explosive increase in opioid-related deaths, which can be traced to the use of other opioids, specifically heroin and illicit synthetic fentanyl as highlighted nationwide. More recently, an explosive increase in opioid-related deaths can be traced to the use of other opioids, specifically heroin and illicit synthetic fentanyl as highlighted in multiple states. As an example, fentanyl-related deaths spiked to 139 between 2015 and 2016.
The ASIPP opioid guidelines also take into consideration public opinion, wherein a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report a better quality of life.
A multidisciplinary, diverse panel consisting of 60 specialists from across the nation worked to prepare these guidelines, focusing on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use.
Click HERE to read guidelines
|
|
|
Aetna CEO says ObamaCare in 'death spiral'
|
|
|
Are Emergency Docs Prescribing Too Many Opioids?
|
|
Opioid prescribing patterns among emergency physicians varied within individual hospitals, according to a large analysis of Medicare Part D beneficiaries.
Within the same hospital, high- and low-prescribing emergency physicians differed significantly in their rate of prescribing opioids to Medicare patients discharged home (24.1% versus 7.3%, P<0.001), wrote Michael L. Barnett, MD, of the Harvard T.H. Chan School of Public Health, and colleagues in the study in New England Journal of Medicine.
MedPage Today
|
|
|
Policy Papers on ACA Repeal: Many Question, Few Answers
|
|
|
Health Care Spending Expected to Increase 5.6% Annually to 2025
HealthDay News -- According to a report published in Health Affairs, health care spending is expected to grow at an average annual rate of 5.6% from 2016 to 2025.
Sean Keehan, from the US Centers for Medicare and Medicaid Services in Baltimore, and colleagues address the national health expenditure projections for time period. The researchers note that for 2016 to 2025, national health expenditures are expected to grow at an annual rate of 5.6%; by 2025, expenditures are expected to represent 19.9% of the gross domestic product.
Clinical Pain Advisor
|
|
|
OHSIPP Meeting
August 25-27, 2017
The Ohio Society of Interventional Pain Physicians (OHSIPP) has set the dates for its 2017 meeting.
Dates are Friday Aug 25 thru Sunday Aug 27, 2017.
The meeting will be held in Cincinnati at the Westin Hotel, 21 E 5th St , at Fountain Square .
Contact Michelle Byers for more information MichelleHByers@gmail.com
FSIPP Meeting
August 27 - 30, 2017
The Florida Society of Interventional Pain Physicians (FSIPP) has set the dates for its 2017 meeting
Dates are April 27-30, 2107
The meeting will be held in Orlando, FL at the Orlando World Center Marriott
Click Here for more information and to make reservation
|
|
|
|
|
|
|
